Single Ventricle Outcome
NCT00308217
Cardiovascular Abnormalities, Cardiovascular Diseases
Atlanta, Georgia, United States
View Trial DetailsNCT Number: NCT00276237
One of the most common residual lesions in adult survivors of pediatric cardiac surgery is pulmonary valve disease, particularly regurgitation.
Multiple studies have demonstrated that placement of a pulmonary valve in such patients, results in improved ventricular function and resolution of symptoms. However, the optimal prosthetic valve for use in the pulmonary position has not been defined. There are essentially three alternatives available: the stented bioprosthetic valve, stentless bioprosthetic "tube" grafts used to replace the entire right ventricular outflow tract and mechanical valves.
All three of these valve options have been used in adults with congenital heart disease at Emory Healthcare and at Children's Healthcare of Atlanta at Egleston.
The goal of this study is to evaluate and compare the indications and short and mid-term outcomes for these alternative therapies.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Adult patients who have received a pulmonary valve replacement for congenital heart disease at Children's Healthcare of Atlanta at Egleston or are in the Emory Healthcare System between 1976 and 2004.
-
Exclusion criteria
-
Emory University
Other
Review of Outcomes Following Pulmonary Valve Replacement for Congenital Heart Disease in Adults
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00308217
Cardiovascular Abnormalities, Cardiovascular Diseases
Atlanta, Georgia, United States
View Trial DetailsNCT07066748
Cardiovascular Abnormalities, Cardiovascular Diseases
Alexandria, Alexandria Governorate, Egypt
View Trial DetailsNCT01952171
Cardiovascular Abnormalities, Cardiovascular Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT05767385
Cardiovascular Abnormalities, Cardiovascular Diseases
San Francisco, California, United States
View Trial Details